Sign in

CIK 0000744218 · Large accelerated filer

Celldex Therapeutics, Inc.

Sign in to watch
Ticker
CLDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133191702
Phone
908-200-7500
Business address
53 FRONTAGE ROAD, SUITE 220, HAMPTON, NJ, 08827
Former names
AVANT IMMUNOTHERAPEUTICS INC, T CELL SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-06-13 KELER TIBOR Executive VP & CSO Grant or award · Incentive Stock Option (right to buy) +390,000 390,000
2018-06-13 Marucci Anthony S President & CEO Grant or award · Incentive Stock Option (right to buy) +1,075,000 1,075,000
2018-06-13 Brownlie Keith L Director Grant or award · Non-Qualified Stock Option (right to buy) +67,000 67,000
2018-06-13 MARINO JAMES J Director Grant or award · Non-Qualified Stock Option (right to buy) +67,000 67,000
2018-06-13 McMahon Gerald PhD Director Grant or award · Non-Qualified Stock Option (right to buy) +67,000 67,000

Page 17 of 17 · 325 trades